Publicaciones en las que colabora con MARÍA ÁNGELES MORO SÁNCHEZ (23)

2024

  1. Myeloid cells in vascular dementia and Alzheimer's disease: Possible therapeutic targets?

    British Journal of Pharmacology, Vol. 181, Núm. 6, pp. 777-798

  2. The role of gut microbiota in cerebrovascular disease and related dementia

    British Journal of Pharmacology, Vol. 181, Núm. 6, pp. 816-839

2023

  1. Defective hippocampal neurogenesis underlies cognitive impairment by carotid stenosis-induced cerebral hypoperfusion in mice

    Frontiers in Cellular Neuroscience, Vol. 17

  2. Ipsilesional Hippocampal GABA Is Elevated and Correlates With Cognitive Impairment and Maladaptive Neurogenesis After Cortical Stroke in Mice

    Stroke, Vol. 54, Núm. 10, pp. 2652-2665

2022

  1. Caracterización de la neurogénesis maladaptativa y el deterioro cognitivo post-ictus en un modelo experimental de isquemia cerebral inducida mediante cloruro férrico en ratón

    Dianas: revista de dianas terapéuticas, Vol. 11, Núm. 2

  2. Del laboratorio a la clínica en el ictus isquémico agudo. Modelos experimentales in vitro e in vivo

    Revista de neurologia, Vol. 75, Núm. 9, pp. 283-293

  3. Neutrophil Extracellular Trap Targeting Protects Against Ischemic Damage After Fibrin-Rich Thrombotic Stroke Despite Non-Reperfusion

    Frontiers in Immunology, Vol. 13

2021

  1. Pathophysiological and pharmacological relevance of TLR4 in peripheral immune cells after stroke

    Pharmacology and Therapeutics, Vol. 228

  2. Role of TLR4 in Neutrophil Dynamics and Functions: Contribution to Stroke Pathophysiology

    Frontiers in Immunology, Vol. 12

2019

  1. Abolition of aberrant neurogenesis ameliorates cognitive impairment after stroke in mice

    Journal of Clinical Investigation, Vol. 129, Núm. 4, pp. 1536-1550

  2. Delayed effects of acute reperfusion on vascular remodeling and late-phase functional recovery after stroke

    Frontiers in Neuroscience, Vol. 13, Núm. JUL

  3. Pharmacological Modulation of Neutrophil Extracellular Traps Reverses Thrombotic Stroke tPA (Tissue-Type Plasminogen Activator) Resistance

    Stroke, Vol. 50, Núm. 11, pp. 3228-3237

  4. Role of TLR4 (Toll-Like Receptor 4) in N1/N2 Neutrophil Programming After Stroke

    Stroke, Vol. 50, Núm. 10, pp. 2922-2932

  5. Toll-like receptor 4 regulates subventricular zone proliferation and neuroblast migration after experimental stroke

    Brain, Behavior, and Immunity, Vol. 80, pp. 573-582

2018

  1. AhR deletion promotes aberrant morphogenesis and synaptic activity of adult-generated granule neurons and impairs hippocampus-dependent memory

    eNeuro, Vol. 5, Núm. 4

  2. Iron Overload Exacerbates the Risk of Hemorrhagic Transformation After tPA (Tissue-Type Plasminogen Activator) Administration in Thromboembolic Stroke Mice

    Stroke, Vol. 49, Núm. 9, pp. 2163-2172

  3. Myeloid cells as therapeutic targets in neuroinflammation after stroke: Specific roles of neutrophils and neutrophil–platelet interactions

    Journal of Cerebral Blood Flow and Metabolism, Vol. 38, Núm. 12, pp. 2150-2164

  4. TLR4-Binding DNA Aptamers Show a Protective Effect against Acute Stroke in Animal Models

    Molecular Therapy, Vol. 26, Núm. 8, pp. 2047-2059

2017

  1. Specific Features of SVZ Neurogenesis after Cortical Ischemia: A Longitudinal Study

    Scientific Reports, Vol. 7, Núm. 1

  2. Toll-Like Receptor 4 Mediates Hemorrhagic Transformation after Delayed Tissue Plasminogen Activator Administration in In Situ Thromboembolic Stroke

    Stroke, Vol. 48, Núm. 6, pp. 1695-1699